Colgate-Palmolive Co
NYSE:CL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Colgate-Palmolive Co
NYSE:CL
|
US |
|
E
|
Eli Lilly and Co
XHAM:LLY
|
US |
|
WuXi AppTec Co Ltd
SSE:603259
|
CN |
|
P
|
Perfect Corp
NYSE:PERF
|
TW |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
US |
Wall St Price Targets
CL Price Targets Summary
Colgate-Palmolive Co
According to Wall Street analysts, the average 1-year price target for CL is 96.8093 USD with a low forecast of 75.75 USD and a high forecast of 110.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CL's stock price target?
Price Target
96.8093
USD
According to Wall Street analysts, the average 1-year price target for CL is 96.8093 USD with a low forecast of 75.75 USD and a high forecast of 110.25 USD.
What is the Revenue forecast for Colgate-Palmolive Co?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Colgate-Palmolive Co?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Colgate-Palmolive Co?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 12%.
